366 related articles for article (PubMed ID: 29862557)
61. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
[TBL] [Abstract][Full Text] [Related]
62. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
63. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Isaacs JT; Coffey DS
Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
[TBL] [Abstract][Full Text] [Related]
64. Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis.
Kim HJ; Jin BR; An HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445725
[TBL] [Abstract][Full Text] [Related]
65. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
66. Linh Phu Khang Tue Tinh inhibited prostate proliferation in rats induced benign prostatic hyperplasia by testosterone propionate.
Minh TD; Thanh Ha TN; Duy TN; Hoang NN; PhamTien D; Thai HP; Thi HN; Thi Lan PD; Quoc BP; Ivkin DY; Povydysh MN; Cong BN; Krasnova MV
J Ethnopharmacol; 2021 Oct; 279():114388. PubMed ID: 34224813
[TBL] [Abstract][Full Text] [Related]
67. In vivo evaluation of hot water extract of Acorus gramineus root against benign prostatic hyperplasia.
Moon JM; Sung HM; Jung HJ; Seo JW; Wee JH
BMC Complement Altern Med; 2017 Aug; 17(1):414. PubMed ID: 28830494
[TBL] [Abstract][Full Text] [Related]
68. Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats.
Gong GY; Xi SY; Li CC; Tang WL; Fu XM; Huang YP
Phytomedicine; 2023 Nov; 120():155048. PubMed ID: 37651753
[TBL] [Abstract][Full Text] [Related]
69. Effect of methanol extract of Plectranthus esculentus N.E.Br tuber and its fractions on indices of benign prostatic hyperplasia in Wistar rats.
Kanu SC; Ejezie FE; Ejezie CS; Eleazu CO
J Ethnopharmacol; 2024 Sep; 331():118301. PubMed ID: 38735419
[TBL] [Abstract][Full Text] [Related]
70. Heat-Killed and Live
Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
[TBL] [Abstract][Full Text] [Related]
71.
Kim M; Tran P; Yin J; Song J; Kim H
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839177
[TBL] [Abstract][Full Text] [Related]
72. Methyl Jasmonate Ameliorates Testosterone Propionate-induced Prostatic Hyperplasia in Castrated Wistar Rats.
Akanni OO; Abiola OJ; Adaramoye OA
Phytother Res; 2017 Apr; 31(4):647-656. PubMed ID: 28211173
[TBL] [Abstract][Full Text] [Related]
73. Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model.
Kim SK; Seok H; Park HJ; Jeon HS; Kang SW; Lee BC; Yi J; Song SY; Lee SH; Kim YO; Chung JH
BMC Complement Altern Med; 2015 Oct; 15():380. PubMed ID: 26490686
[TBL] [Abstract][Full Text] [Related]
74. Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia.
Kim KS; Yang HY; Chang SC; Kim YM; Lee KY; Lee BM; Kim HS
Int J Mol Med; 2018 Oct; 42(4):2260-2268. PubMed ID: 30015834
[TBL] [Abstract][Full Text] [Related]
75. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
[TBL] [Abstract][Full Text] [Related]
76. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
77. Antiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats.
Sarbishegi M; Khani M; Salimi S; Valizadeh M; Sargolzaei Aval F
Nephrourol Mon; 2016 Jan; 8(1):e33180. PubMed ID: 26981498
[TBL] [Abstract][Full Text] [Related]
78. [Effects of Xialiqi Capsules on the expressions of PCNA and caspase-3 in rats withbenign prostatic hyperplasia].
Cai HC; Song LB; Zhang GW; Qing XR; Mo DS; Liu W; Zhan XX; Huang YF; Shang XJ
Zhonghua Nan Ke Xue; 2017 Aug; 23(8):728-733. PubMed ID: 29726649
[TBL] [Abstract][Full Text] [Related]
79. Anti-Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia.
Chung KS; Shin SJ; Lee NY; Cheon SY; Park W; Sun SH; An HJ
Phytother Res; 2016 Jul; 30(7):1197-203. PubMed ID: 27191676
[TBL] [Abstract][Full Text] [Related]
80. Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation.
Zhang B; Chen X; Gan Y; Li BS; Wang KN; He Y
Ann Transl Med; 2021 Aug; 9(15):1246. PubMed ID: 34532383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
